Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George Saviolakis, MD
DynPort Vaccine Company, a CSC Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Benchmark Research
San Francisco, California, United States
- Apex Research Institute
Santa Ana, California, United States
- Johnson County Clinical Trials
Lenexa, Kansas, United States
- Heartland Reseach Assoicates, Llc
Wichita, Kansas, United States
- Central Kentucky Research Associates
Lexington, Kentucky, United States
- Wrair Clinical Trials Center
Silver Spring, Maryland, United States
- Center for Pharmceutical Research
Kansas City, Missouri, United States
- Rochester Clinical Research
Rochester, New York, United States
- Wake Research Associates
Raleigh, North Carolina, United States
- Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
- New Orleans Center for Clinical Research
Knoxville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 31 May 2012
- Completion
- 31 Jul 2012
- Last update posted
- 30 Jul 2020
- Registered enrollment
- 402
- Registry id
- NCT01122784
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.